Therme Group
Private Equity Round in 2025
Therme Group is a global company specializing in the development and operation of wellbeing resorts. Their mission is to create spaces that promote health and fulfillment, benefiting both individuals and cities. Therme Group's flagship project, Therme Bucharest, is Europe's largest leisure facility, attracting over 1.2 million visitors in its inaugural year. The company's success is underpinned by a culture of excellence, integrity, and teamwork.
Land's End is a multichannel retail company. The company operates through two segments, Direct and Retail. It offers casual clothing, accessories, footwear, and home products. The company sells its products through its e-commerce Websites, direct mail catalogs, and Lands’ End Shops at Sears.
Land’s End was founded in 1963 and is headquartered in the United States.
Club Car Wash
Acquisition in 2023
Club Car Wash provides car washing and detailing services for vehicle owners in the United States, offering a range of services including bug prevention, tire shining, coating and polishing, underbody cleaning, and wheel cleaning to deliver reliable and cost-effective car care.
Express Wash Concepts
Acquisition in 2023
Express Wash Concepts operates a chain of car washing facilities dedicated to delivering exceptional customer service and high-quality vehicle cleaning experiences. The company focuses on providing comprehensive maintenance and cleaning services for vehicle owners, specializing in car washing and vacuum cleaning. By prioritizing customer satisfaction, Express Wash Concepts aims to create a reliable and efficient environment for customers to care for their vehicles.
Sharp peptide
Series A in 2023
Sharp peptide life is a manufacturer and seller of fungus peptide liquid.
Grove Collaborative
Post in 2022
Founded in 2016 as a Certified B Corporation, Grove Collaborative is an online retailer dedicated to transforming consumer products into a positive force for human and environmental good. It offers a curated selection of high-performing, planet-first products across household cleaning, personal care, laundry, clean beauty, and pet categories, serving millions of households in the U.S. Every product offered by Grove has been vetted against strict standards for clean ingredients, efficacy, sustainability, cruelty-free formulas, and ethical supply chain practices. As a public benefit corporation, Grove is committed to its mission of moving Beyond Plastic, aiming to be 100% plastic-free by 2025.
Grove Collaborative
Venture Round in 2020
Founded in 2016 as a Certified B Corporation, Grove Collaborative is an online retailer dedicated to transforming consumer products into a positive force for human and environmental good. It offers a curated selection of high-performing, planet-first products across household cleaning, personal care, laundry, clean beauty, and pet categories, serving millions of households in the U.S. Every product offered by Grove has been vetted against strict standards for clean ingredients, efficacy, sustainability, cruelty-free formulas, and ethical supply chain practices. As a public benefit corporation, Grove is committed to its mission of moving Beyond Plastic, aiming to be 100% plastic-free by 2025.
Blue Source
Private Equity Round in 2008
Blue Source is a climate change offset group based in North America, focused on publicly registered third-party verified ghg offsets, historical ghg offset sales and ghg offset types.
FibroGen
Venture Round in 2005
FibroGen is a biotechnology company dedicated to discovering, developing, and commercializing innovative therapeutics for serious unmet medical needs. It focuses on connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology, with key products including Roxadustat for anemia in chronic kidney disease and Pamrevlumab for various fibrotic diseases and cancers.
Acuity Pharmaceuticals
Series B in 2004
Acuity Pharmaceuticals is a pharmaceutical company based in Philadelphia, Pennsylvania, that specializes in developing treatments for ophthalmic diseases, particularly age-related macular degeneration and diabetic retinopathy. Founded in 2007, the company focuses on innovative therapies, including its clinical compound Cand5, a small interfering RNA therapeutic designed to treat vision loss by targeting vascular endothelial growth factor. In June 2011, Acuity Pharmaceuticals was acquired by OPKO Health, further enhancing its capabilities in the field of eye care.